Abnormal amyloid PET usually represents intermediate/high Alzheimer's disease neuropathologic change

作者信息Brian J Burkett, Heather J Wiste, Derek R Johnson, Bradley F Boeve, Kejal Kantarci, Ronald C Petersen, David S Knopman, Prashanthi Vemuri, Jonathan Graff-Radford, Val Lowe, Petrice M Cogswell, Jay Pillai, Christopher G Schwarz, Aivi T Nguyen, Melissa E Murray, Dennis W Dickson, Clifford R Jack Jr
PMID42092343
期刊Alzheimers Dement
发布时间2026-05
DOI10.1002/alz.71449
查看来源

摘要

Introduction: Alzheimer's disease neuropathologic change (ADNC) classification identifies not/low and intermediate/high levels of neuropathology. Our goal was to assess how frequently a positive amyloid positron emission tomography (PET) scan indicates not/low ADNC and whether this autopsy finding can occur >10 years after a positive amyloid PET. Methods: Participants with positive amyloid PET scans were categorized by levels of ADNC at autopsy, grouped by time from initial positive amyloid PET to time of death (<5 years, 5 to <10 years, or 10+ years). Results: Among those with a positive amyloid PET scan, the majority had intermediate/high ADNC at autopsy (234/259, 90%). In the group with 10+ years between a positive amyloid PET and death (n = 39) not/low ADNC occurred in 3/39 (8%). Discussion: Not/low ADNC is uncommon among those with positive amyloid PET scans. After 10+ years, it is possible but rare for a positive amyloid PET scan to represent an indolent state of neuropathology.

实验方法